Those buying OBJ at these levels may be one day very soon be grateful to the sellers and/or Vice Versa should what we anticipate in the near term not come to fruition.
In regards to indepth knowledge of ANP shared on HC, I would personally recommend scrolling through some of, "AcesHigh's" quality contributions on that thread. Our own "Surges" may also have a better understanding for antisense technology than I.
"...for a company with such potential the market just doesnt seem to appreciate it, I often think I'm missing something?"
Any person who references BLT (or OBJ) with the comment you make above confirms to me that you "HAVE" done your homework. However, I guess knowledge won't make us wealthy, it will only make us wise
ddRNAi technology holds tremendous promise, has much wider applications than what I believe antisense technology does, and I can say with a high degree of confidence, that it is many times more efficient.
Most of the information I have gained in regards to RNAi therapeutics is from a Prof Haussecker at Dongguk University in Seoul. Fyi, below is a link to one of his recent papers published in the Nature Journal titled, "The Business of RNAi Therapeutics in 2012 - Dirk Haussecker"
If like myself you struggle to absorb most of the scientific jargon relating to RNAi therapeutics, you'll probably find more value in his Blogspot below, which comments on the basic science of everything from Benitec's ddRNAi technology to Dicer, and clinical issues as well as investment opportunities - RNAi Therapeutics Blogspot
One of the reasons I have changed my investment strategy in regards to taking a more cautious approach for investing in Drug Discovery companies like ANP or BLT, is because of my belief that the Human Genome Project will allow us to find many cures to diseases well before the good majority of our Drug companies make it to late stage studies. I believe it's also very important for L/Term Biotech investors to try and pay careful attention to the direction Big Pharma are moving - Imo, very much can be gained from this knowledge for what lies ahead, a change we are certainly witnessing today
Craig Venter is a name that not too many people would know, but he recently made Time Magazine's list of 100 Most Influential People in the World, and the New York Times called him, one of this era's most electrifying scientists
In 2001, Craig Venter made headlines for sequencing the human genome. In 2003, he started mapping the ocean's biodiversity. And now he's created the first synthetic lifeforms - microorganisms that can produce alternative fuels. In May 2010, Craig Venter and his team make a historic announcement: they've created the first fully functioning, reproducing cell controlled by synthetic DNA. He explains how they did it and why the achievement marks the beginning of a new era for science.
Craig Venter unveils "synthetic life"
This following presentation is from one of my favorite speakers, Juan Enriquez - who thinks and writes about profound changes that genomics will bring in business, technology, and society. - He was the founding director of the Harvard Business School Life Sciences Project - Recommended viewing.
Juan Enriquez: Will our kids be a different species?
OBJ Price at posting:
1.6¢ Sentiment: LT Buy Disclosure: Held
(20min delay)